Cong Wang

Cong Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
HCHongbo Chen
Hongbo Chen
YDYindi Dai
Yindi Dai
JLJiyu Liu
Jiyu Liu
LDLianmao Duan
Lianmao Duan
JHJuan Hu
Juan Hu
NZNingning Zhao
Ningning Zhao
The prevalence of chicken coccidiosis in the poultry industry is a significant concern, further exacerbated by the emergence of drug-resistant coccidia resulting from the indiscriminate use of medications. Ethanamizuril, a novel triazine anti-coccidial compound, has been used to combat drug resistance. Currently, it is known that Ethanamizuril acts on the second-generation merozoites and early gametogenesis stages of Eimeria. Limited information exists regarding its impact on the early merozoites and exogenous stage of Eimeria. In the present study, the anti-coccidial properties of Ethanamizuril were evaluated both in vitro and in vivo. The in vitro experiments demonstrated that Ethanamizuril effectively inhibits the sporulation of E. tenella oocysts in a dose-dependent manner and significantly reduces the sporozoite excystation rate. Furthermore, in vivo tests revealed that treatment with 10 mg/L Ethanamizuril in drinking water significantly decreased the copy number of first-generation and secondary-generation merozoites in the chicken cecum, indicating that it can inhibit the development of whole schizonts development. Moreover, treatment with Ethanamizuril demonstrated excellent protective efficacy with an anti-coccidial index (ACI) of 180, which was manifested through higher body weight gains, lighter cecal lesion, lower fecal oocyst shedding score and reduced liver index. Collectively, this study suggests that Ethanamizuril effectively treats E. tenella infection by inhibiting both endogenous and exogenous stages development.

1 January 2025 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
HZHaojie Zhang
Haojie Zhang
QSQiwei Song
Qiwei Song
XWXu Wang
Xu Wang
XYXiaoxue Yue
Xiaoxue Yue
ZWZhikui Wang
Zhikui Wang
XCXiulei Cai
Xiulei Cai
Glaesserella parasuis, the causative agent responsible for Glässer's disease in swine, leads to severe polyserositis, meningitis, and arthritis, posing a significant threat to swine production. The LuxS/AI-2 quorum sensing system is crucial for G. parasuis growth, biofilm formation, and pathogenicity. Quorum sensing inhibitors, such as paeoniflorin (PF), offer a potential strategy to mitigate antibiotic resistance. This study evaluated PF’s effects, alone and combined with antibiotics, on quorum sensing, biofilm formation, and virulence gene expression of drug-resistant G. parasuis. PF significantly reduced AI-2 production, biofilm formation, and virulence genes expression in vitro. A viable model for G. parasuis infection was established using KM mice, and demonstrated that a low-dose combination of PF and lincomycin effectively mitigated organ damage, reduced bacterial load in the liver, and improved survival rates compared to individual treatments in vivo. These findings suggest PF as a promising quorum sensing and virulence inhibitor for controlling G. parasuis infections. Further research is warranted to optimize its clinical application.

9 April 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
ZZZhendong Zhang
Zhendong Zhang
CWCong Wang
Cong Wang
CWChengyue Wu
Chengyue Wu
QWQingteng Wei
Qingteng Wei
ZYZhengqin Ye
Zhengqin Ye
Xiangdong LiXiangdong Li
Xiangdong Li
Pseudorabies virus (PRV) remains a critical threat for the global swine industry, with heightened attention due to the emergence of variant strains since late 2011 in China. Emergent viral variants generally undergo three to four years of adaptation to present new phenotypes. However, limited investigations have been performed on the evolution and pathogenicity of variant PRV strains in growing pigs after 2015. In this study, three PRV field strains, named SD1501, SD1701, and SD1801, were isolated and their genetic characteristics and pathogenicity on 9-week-old pigs were analyzed. Nucleotide identity and phylogenetic analyses based on the complete genome sequence, as well as major immunogenic and virulence-related genes revealed that all three isolates clustered closely with genotype II variant strains prevalent in China. The pathogenicity analysis demonstrated that the three isolates exhibited moderate pathogenicity in growing pigs with a TCID50 of 107. Infected pigs displayed transient fever and reduced appetite, with only one pig in each challenge group showing typical neurological symptoms and succumbing within 6 days post infection. These findings enrich the epidemiological data of PRV and provide direct evidence for the phenotypic variations caused by PRV infection, which enhances our understanding of PRV evolution in China and contributes to PRV control in the field.

27 April 2026 in The Veterinary Journal
Verified
Journal Article
Closed access
SXShiyu Xu
Shiyu Xu
XCXiaojin Chen
Xiaojin Chen
FMFeifei Meng
Feifei Meng
YZYing Zhang
Ying Zhang
JLJiayi Liao
Jiayi Liao
ZZZhibang Zhang
Zhibang Zhang

10 February 2026 in Veterinary Research Communications
Verified
Journal Article
Open access
PDF file
XLXianhai Luo
Xianhai Luo
GZGuangshan Zhu
Guangshan Zhu
YDYindi Dai
Yindi Dai
GZGang Zhang
Gang Zhang
JWJin Wan
Jin Wan
ZQZhixia Qiu
Zhixia Qiu
Background Tylvalosin (acetylisovaleryltylosin), a breakthrough semi-synthetic derivative of tylosin engineered to address pharmacokinetic limitations and bacterial resistance, exhibits dual therapeutic efficacy against porcine reproductive and PRRSV-associated pneumonia and mycoplasma infections in swine. Limited research has yet to investigate pharmacokinetic profiles of tylvalosin and its metabolites. This study, therefore, aims to pioneer a robust UPLC-MS/MS method for simultaneous quantification of tylvalosin and its key bioactive metabolites, desmycosin 3-acetate and tylosin 3-acetate, in swine plasma and tissues, and to investigate the pharmacokinetic properties of different tylvalosin formulations. Results A robust UPLC-MS/MS method was developed and validated, showing excellent performance with good linearity, low deviation, high accuracy, minimal carry-over and matrix effects, as well as favorable stability under various conditions. Pharmacokinetic analysis following intravenous (i.v.) or intragastric administration in swine revealed that formulation I outperformed other formulations, exhibiting the highest bioavailability (F, 57.32%), the longest elimination half-life (t1/2, 7.93 h), and a delayed time to maximum plasma concentration (tmax, 3.14 h). Dose-normalized metabolites exposures were also significantly higher for formulation I compared to other formulations. Critically, tylvalosin and its metabolites preferentially accumulated in pulmonary and lymphatic tissues at 48 h post-administration, indicating rapid absorption, swift metabolism, and slow elimination. Conclusions The findings confirm the optimized therapeutic potential of tylvalosin, particularly formulation I, supported by its favorable pharmacokinetic profile and tissue distribution. This study establishes a new standard for veterinary PK-PD research and provides a PK evidence-based formulation optimization approaches to enhance treatment efficacy.

13 August 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JLJiyu Liu
Jiyu Liu
YDYuexin Dong
Yuexin Dong
ZXZhongxing Xu
Zhongxing Xu
JZJinyong Zhang
Jinyong Zhang
LDLianmao Duan
Lianmao Duan
XWXuexia Wen
Xuexia Wen
Porcine Rotavirus ( PoRV ), a major pathogen causing diarrhea in piglets and significant economic losses, exhibits high genotypic diversity and poses a risk of cross-species transmission. PoRV infection is initiated by the interaction of its outer capsid proteins, VP4 and VP7, with multiple host cell receptors (e.g., sialic acids, integrins), triggering complex processes of endocytosis and membrane penetration that ultimately lead to enterocyte dysfunction and diarrhea. Diverse immune evasion strategies have been evolved by PoRV , among which the host interferon responses and cellular protein synthesis are both suppressed by nonstructural proteins including NSP1 and NSP3. Host defense relies on innate immunity (e.g., RIG-I/MDA-5 and TLR3 signaling pathways) and adaptive immunity centered on virus-specific T cells. Epidemiological surveillance indicates the dominance of RVA genotypes in swine populations worldwide. Furthermore, genetic reassortment events between porcine and human strains underscore a significant zoonotic transmission risk, which poses a significant challenge to public health and compromises the efficacy of existing vaccines. Current control measures rely on biosecurity management and vaccination to enhance maternal antibody transfer. However, given the high genetic variability of the virus, the development of novel broad-spectrum vaccine platforms, such as those based on virus-like particles (VLPs) or multi-epitope antigens, is urgently needed. In this review, current research progress is systematically integrated to advance the understanding of PoRV -host interactions and provide evidence-based guidance for the development of effective control strategies.